RAPID AND SUSTAINED IMPROVEMENT IN SLEEP QUALITY, ANXIETY, AND DEPRESSION IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB TREATMENT

被引：0
|
作者：
Merola, Joseph F. [1 ]
Chiou, Albert S. [2 ]
During, Emmanuel [2 ]
Foley, Peter [3 ]
Ardeleanu, Marius [4 ]
Wu, Jiangming [5 ]
Ozturk, Zafer E. [6 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Stanford Univ, Palo Alto, CA USA
[3] Skin Hlth Inst, Carlton, Vic, Australia
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Bridgewater, NJ USA
[6] Sanofi, Cambridge, MA USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P8.23
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [41] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [42] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [43] PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Simpson, E.
    Lacour, J.
    Beck, L.
    Zhang, H.
    Aamodt, K.
    Rossi, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S55 - S56
  • [44] Baseline serum biomarkers do not predict dupilumab treatment response in adults with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Beck, Lisa A.
    de Bruin-Weller, Marjolein S.
    Thyssen, Jacob P.
    Kabashima, Kenji
    Guttman-Yassky, Emma
    Akdis, Cezmi A.
    Chen, Zhen
    Levit, Noah A.
    Bastian, Mike
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [45] Advances in Systemic Treatment for Adults With Moderate-to-Severe Atopic Dermatitis
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2019, 37 (01) : 3 - 11
  • [46] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [47] Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Praestgaard, Amy
    Prescilla, Randy
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [48] EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis
    Agache, Ioana
    Akdis, Cezmi
    Akdis, Mubeccel
    Brockow, Knut
    Chivato, Tomas
    del Giacco, Stefano
    Eiwegger, Thomas
    Eyerich, Kilian
    Gimenez-Arnau, Ana
    Gutermuth, Jan
    Guttman-Yassky, Emma
    Maurer, Marcus
    Ogg, Graham
    Ong, Peck Y.
    O'Mahony, Liam
    Schwarze, Juergen
    Warner, Amena
    Werfel, Thomas
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2021, 76 (04) : 988 - 1009
  • [49] Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
    Andrew Blauvelt
    Marjolein de Bruin-Weller
    Eric L. Simpson
    Zhen Chen
    Marius Ardeleanu
    Ana B. Rossi
    Dermatology and Therapy, 2022, 12 : 9 - 13
  • [50] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
12345